A review of clinical and histological features of Spanish paediatric medulloblastomas during the last 21 years

Child's Nervous System

Volumn 22, Issue 5, 2006, Pages 466-474

  Urberuaga, Alejandro ^a   Navajas, Aurora ^a   Burgos, Juan ^a   Pijoán, José Ignacio ^a  

^a HOSPITAL DE CRUCES   (Spain)

Author keywords

Clinical characteristics; Histological parameters; Medulloblastoma; Prognostic factors

Indexed keywords

ANTINEOPLASTIC AGENT; PARAFFIN;

ADOLESCENT; ADULT; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CEREBELLUM VERMIS; CEREBROSPINAL FLUID SHUNTING; CHILD; CLINICAL FEATURE; DISEASE DURATION; DISEASE FREE SURVIVAL; FEMALE; HEADACHE; HISTOPATHOLOGY; HUMAN; HYDROCEPHALUS; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PAPILLEDEMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; SPAIN; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL RATE; TUMOR CLASSIFICATION; TUMOR LOCALIZATION; UNIVARIATE ANALYSIS; VOMITING;

CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEDULLOBLASTOMA; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SPAIN;

EID: 33646144001     PISSN: 02567040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00381-005-0004-4     Document Type: Review

References (30)

1. Peris-Bonet R, Giner B, García A et al (2003) Registro Nacional de Tumores Infantiles. Estadísticas básicas 4. 1980-2001, Supervivencia 1980-1997.Universitat de València, Valencia
2. Muñoz A (1997) Introducción a la oncologia pediátrica. In: Madero L, Muñoz A (eds) Hematología y oncología pediátricas. Ergon, Madrid, pp 197-206
3. Strother DR, Pollack IF, Fisher PG et al (2002) Tumors of the central nervous system. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology, 4th edn. Lippincott, Philadelphia, pp 751-824
4. Taylor RE, Bailey CC, Robinson K et al (2003) Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study. J Clin Oncol 21:1581-1591
5. Packer RJ, Goldwein J, Nicholson HS et al (1999) Treatment of children with medulloblastoma with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. J Clin Oncol 17:2127-2136
6. Freeman CR, Taylor RE, Kortmann RD, Carrie C (2002) Radiotherapy for medulloblastoma in children: A perspective on current international clinical research efforts. Med Pediatr Oncol 39:99-108
7. Zeltzer PM, Boyett JM, Finlay JL et al (1999) Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: Conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 17:832-845
8. Yock TI, Friedman H, Kun L, Kepner J, Barnes P, Tarbell NJ (2001) Response to pre-radiation chemotherapy is predictive of improved survival in high-risk medulloblastoma: Results from Pediatric Oncology Group (POG 9031). Int J Radiat Oncol Biol Phys 51 (3 Suppl 1):S120-S121
9. Dennis M, Spiegler BJ, Hetherington CR, Greenberg ML (1996) Neuropsychological sequelae of the treatment of children with medulloblastoma. J Neurooncol 29:91-101
10. Walter AW, Mulhern RK, Gajjar A et al (1999) Survival and neurodevelopmental outcome of young children with medulloblastoma at St. Jude Children's Research Hospital. J Clin Oncol 17:3720-3728
11. Duffner PK, Cohen ME, Anderson SW et al (1983) Long-term effects of treatment on endocrine function in children with brain tumors. Ann Neurol 14:528-532
12. Schell MJ, McHaney VA, Green AA et al (1989) Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. J Clin Oncol 7:754-760
13. Stavrou T, Bromley CM, Nicholson HS et al (2001) Prognostic factors and secondary malignancies in childhood medulloblastoma. J Pediatr Hematol Oncol 23:431-436
14. Packer RJ, Boyett JM, Janss AJ et al (2001) Growth hormone replacement therapy in children with medulloblastoma: Use and effect on tumor control. J Clin Oncol 19:480-487
15. Albright AL, Wisoff JH, Zeltzer PM, Boyett JM, Rorke LB, Stanley P (1996) Effects of medulloblastoma resections on outcome in children: A report from the Children's Cancer Group. Neurosurgery 38:265-271
16. Giangaspero F, Perilongo G, Fondelli MP et al (1999) Medulloblastoma with extensive nodularity: A variant with favorable prognosis. J Neurosurg 91:971-977
17. Giangaspero F, Rigobello L, Badiali M et al (1992) Large-cell medulloblastomas. A distinct variant with highly aggressive behavior. Am J Surg Pathol 16:687-693
18. Brown HG, Kepner JL, Perlman EJ et al (2000) "Large cell/ anaplastic" medulloblastomas: A Pediatric Oncology Group Study. J Neuropathol Exp Neurol 59:857-865
19. Eberhart CG, Kepner JL, Goldthwaite PT et al (2002) Histopathological grading of medulloblastomas: A Pediatric Oncology Group study. Cancer 94:552-560
20. Chang CH, Housepian EM, Herbert C Jr (1969) An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 93:1351-1359
21. WHO (2000) WHO classification of tumours of the nervous system. In: Kleihues P, Cavenee WK (eds) Pathology and genetics of tumours of the nervous system. World Health Organization classification of tumours. IARC, Lyon, pp 6-7
22. Hosmer DW Jr, Lemeshow S (1999) Applied survival analysis: Regression modeling of time to event data. Wiley, New York
23. Weil MD, Lamborn K, Edwards MS, Wara WM (1998) Influence of a child's sex on medulloblastoma outcome. JAMA 279:1474-1476
24. Halperin EC, Watson DM, George SL (2000) Duration of symptoms prior to diagnosis is related inversely to presenting disease stage in children with medulloblastoma. Cancer 91:1444-1450
25. Sure U, Berghorn WJ, Bertalanffy H et al (1995) Staging, scoring and grading of medulloblastoma. A postoperative prognosis predicting system based on the cases of a single institute. Acta Neurochir (Wien) 132:59-65
26. Tait DM, Thornton-Jones H, Bloom HJ, Lemerle J, Morris-Jones P (1990) Adjuvant chemotherapy for medulloblastoma: The first multicentre controlled trial of the International Society of Paediatric Oncology (SIOP). Eur J Cancer 26:464-469
27. Frost PJ, Laperriere NJ, Wong CS, Milosevic MF, Simpson WJ, Pintilie M (1995) Medulloblastoma in adults. Int J Radiat Oncol Biol Phys 32:951-957
28. Grotzer MA, Geoerger B, Janss AJ, Zhao H, Rorke LB, Phillips PC (2001) Prognostic significance of ki-67 (MIB-1) proliferation index in childhood primitive neuroectodermal tumors of the central nervous system. Med Pediatr Oncol 36:268-273
29. Miralbell R, Tolnay M, Bieri S et al (1999) Pediatric medulloblastoma: prognostic value of p53, bcl-2, Mib-1, and microvessel density. J Neurooncol 45:103-110
30. Grotzer MA, Wiewrodt R, Janss AJ et al (2001) High microvessel density in primitive neuroectodermal brain tumors of childhood. Neuropediatrics 32:75-79